The modern rehabilitation medicine is an important part of the comprehensive me- cal attendance of hemophiliacs. The necessary multidisciplinary team of specialists is available in a qualitative high-class rehabilitation hospital. Indispensable is the point that the coordinating medical specialist in Rehabilitation Medicine on site is skilled in the treatment of hemophiliacs. But he doesn t want and he can t replace the patient s hematologist. He is just the coordinator of the comprehensive team in the rehabilitation clinic. I hope I have shown that rehabilitation is an important topic for most patients with hemophilia. References 1. Neuntes Sozialgesetzbuch (SGB IX) Rehabilitation und Teilhabe behinderter Menschen vom 19. 6. 2001 (BGBl. I,S. 1046) 2. Kurth A, Kreuz W, Scharrer I: "Die orthopädische Behandlung von muskulo-skelettalen Komplikationen der Hämophilie". Dtsch Arztebl 2002; 99: A 2928 2935 [Heft 44] 3. BAR: Wegweiser Rehabilitation und Teilhabe behinderter Menschen,11. Auflage,Fra- furt/Main 2001 4. BAR und Sozialpsychologisches Institut (Köln): Teamentwicklung in der Rehabilitation, Franfurt/Main Juni 2000 5. Buzzard B, Beeton K: "Physiotherapy, Management of Haemophilia", Blackwell Science, Oxford 2000 6. Rizzo Battistella L: "Rehabilitation in Haemophilia options in the developing world", Haemophilia, 1998, 4, 486 490 7. Beeton K S: "Physiotherapie bei erwachsenen Patienten mit Hämophilie". In Rodriguez- Merchan E C,Goddard N J u. Lee C A (Hrsg): Orthopädische Aspekte der Hämophilie,Stork Medien,Bruchsal 2002 (dt. Übersetzung) 8.

HIV Infection and Causes of Death in Patients with Hemophilia in Germany (Year 2001/2002 Survey)

Hemophilia Registry of the Medical Committee of the Swiss Hemophilia Association - Annual Survey 2002
»New Viruses« and the Safety of Factor Concentrates and Stable Blood Products: TT Virus and West Nile Virus as Current Examples
A Retrospective Study on the Development of Inhibitors after Continuous Infusion of Factor VIII
Characterization of Factor VIII-Inhibitory Antibodies Using Phage Display
Rituximab - A new Treatment of Acquired Hemophilia A?
Thrombin Generation and Thrombogram: Assays for Monitoring Factor VIII Bypassing Therapies
Rehabilitation - A Topic for Hemophiliacs?
Functional Analysis as a Basis for Optimizing Physiotherapy in Hemophilic Children
Sport and Physical Fitness Recommendations for Young Hemophiliacs
Pain Versus Clinical and Radiological Assessment in Hemophilic Arthropathies
Endogenous Thrombin Potential in Platelet-Rich Plasma - New Insights Regarding the Different Action of F VIII and F IX
Interactive and Case-Based Training of Diagnostic Skills and Therapeutical Management of Coagulation Disorders with CAMPUS, a Computer-Based Program
Elevated Fibrinogen is a Risk Factor for Arterial Thrombosis in Children
Increased von-Willebrand-Factor-Binding to Platelets in Neonatal Plasma
Neonatal Protein C Deficiency after massive thromboembolic Event of the right upper Limb Treatment with Protein C Concentrate
IMMUNATE S/D - A new Factor VIII - von-Willebrand-Factor Complex Concentrate
Favorable Response to Protein C in Venoocclusive Disease after Allogeneous Stem Cell Transplantation
Phase III Clinical Evaluation of rAHF-PFM Prepared Using a Plasma/Albumin free Method
Anti-Prionin IgG, Possible newSerum Markers for Contact and Infection with Transmissible Spongiform Encephalopathies: Preliminary Results from Screening 100 Blood Donors
Experimental Approaches to Hemophilia Gene Therapy: Gene Transfer into Hematopoietic Stem Cells
Von-Willebrand-Factor Cleaving Protease (ADAMTS-13) Activity in Various Thrombotic, Hemolytic and Autoimmune Disorders
Treatment with Interferon Alpha-2a in Patients with Hepatitis C and Hemophilia
Practical Experiences with Therapies for Chronic Hepatitis C in Hemophilia Patients
Deep Venous Thrombosis of the Lower Extremity in a 16-Year-old Girl with Homozygous MTHFR- and Heterozygous Factor V Leiden-Mutation
Clinical Manifestations of Patients with Highly Elevated Anticardiolipin Antibodies
Progression of an Extensive Deep Vein Thrombosis Under High Dose Therapy with low Molecular Weight Heparin of a 13-4 Year-old Girl Suffering from Colitis Ulcerosa
Hyperfibrinolysis in Hemophagocytic Lymphohistiocytosis
Prolonged Lysis-Therapy of an Arteria Iliaca Externa Thrombosis in a very low Birth Weight Infant with a Variant in the Factor-XIII-Gene
Modified Immunsuppression in a Case of Acquired Hemophilia - Case Report
Life-Threatening Bleeding after Vaccination as a First Manifestation of Hemophilia A
Administration of Protein C-Concentrate (Ceprotin, Baxter) in Purpura Fulminans as the First Clinical Manifestation of Galactosemia
Case Report: Successful Treatment of a Spontaneous Acquired Inhibitor against Factor VIII in a 73-Year old Patient
Medical Need and Quality of Life in Patients with Hemophilia A
Quality of Life Autoevaluation of Hemophilia Patients in Romania
Valproate-Induced Type I von-Willebrand's Disease - a Common Occurrence?
Bleeding Symptoms in Carriers of Hemophilia A - Associationto the Factor VIII Gene Mutation?
Recombinant Human Interferon ?-2b Therapy, for Refractory Immune Thrombocytopenic Purpura in Children
Review on Bleeding Episodes in Hemophiliacs Receiving no Primary Prophylactic Replacement Therapy
Endogenous Thrombin Potential and Thrombin Activatable Fibrinolysis Inhibitor in Patients with Hemophilia and von-Willebrand Disease
Different Thrombotic Risk Factors - Contribution to the Endogenous Thrombin Potential
Coagulation Parameters in Pregnancy: Low-Molecular-Weight Heparin Prophylaxis in Women with Thrombophilic Risk Factors
Malignancy is not Associated with Decreased ADAMTS-13 Activity in Patients with Brain Tumors
Analysis of Factor VIII RNA from Hemophilia A Patients with no Detectable Mutation in the Coding Regions
FISH for Carrier Detection of Large Deletions in the Factor VIII Gene
Homozygosity Mapping of a Second Gene Locus for Hereditary Combined Deficiency of Vitamin-K-Dependent Clotting Factors (FMFD) to Chromosome 16
First Case of Compound Heterozygosity in the Gamma-Glutamyl Carboxylase Gene Causing Combined Deficiency of all Vitamin-K-Dependent Blood Coagulation Factors
Phosphatidylserine in the Neonatal and Adult Platelet Membrane: A Comparison
Low Protein C, Tissue Factor Pathway Inhibitor, and Antithrombin Allow Sufficient Thrombin Generation in Neonatal Plasma.